Enzolytics Inc
Change company Symbol lookup
Select an option...
ENZC Enzolytics Inc
NVOS Novo Integrated Sciences Inc
PAYS Paysign Inc
SELB Selecta Biosciences Inc
HLIO Helios Technologies Inc
AOUT American Outdoor Brands Inc
ZD Ziff Davis Inc
AGAC African Gold Acquisition Corp
LEA Lear Corp
PRT PermRock Royalty Trust
Go

Company profile

Enzolytics, Inc. is a drug development biotechnology company. The Company is engaged in the commercialization of its proteins for the treatment of debilitating infectious diseases. The Company is focused in developing monoclonal antibody therapy and treating infectious diseases. It has anti-HIV therapeutics and a methodology for producing fully human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The Company has clinically tested anti-HIV therapeutics. The Company has developed a cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus. The Company has also created human cell lines that produce human antibodies against other infectious diseases, including rabies, influenza, tetanus, and diphtheria. The Company is testing these antibodies to prepare them for use as therapies against these diseases.

Closing Price
$0.066
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0678
Day's Low
0.0651
Volume
(Light)
Volume:
2,669,546

10-day average volume:
5,318,221
2,669,546
  • Prev Close
    0.066
  • Today's Open
    0.0658
  • Day's Range
    0.0651-0.0678
  • Avg Vol (10-day)
    5.3M
  • Last (time)
    4:03p ET 06/30/22
  • Last (size)
    9.8K
  • 52-Wk Range
    0.0532 - 0.2201
    LowHigh
  • (07/21/21 - 05/24/22)
    24.06%
  • 113.1%
  • Market Cap
    161.0M
  • Shares Outstanding
    2.4B
  • --
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • -1.1
  • 0.02
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.